BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37731438)

  • 1. A Rare Post-infectious Rash: Pityriasis Rubra Pilaris After COVID-19 Infection.
    Duncan P; Flood D; Dietz C
    Cureus; 2023 Aug; 15(8):e43810. PubMed ID: 37731438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Pityriasis Rubra Pilaris Preceding Leukemia.
    Vance P; Wyles S; Alavi A
    Adv Skin Wound Care; 2022 Jun; 35(6):1-4. PubMed ID: 35703855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report.
    Saad M; Spurr A; Lipson J
    SAGE Open Med Case Rep; 2023; 11():2050313X231160927. PubMed ID: 37009550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Presentation of Pityriasis Rubra Pilaris Mimicking Tinea Corporis: Diagnostic Challenges of a Rare Skin Condition.
    Abang Hashim DH; Ismail IA; Tawil Z; Abd Halim H
    Am J Case Rep; 2022 Aug; 23():e936906. PubMed ID: 35988013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bevacizumab-induced pityriasis rubra pilaris-like eruption.
    Brown S; Fletcher JW; Fiala KH
    Proc (Bayl Univ Med Cent); 2016 Jul; 29(3):335-6. PubMed ID: 27365893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Pityriasis Rubra Pilaris: A Case Report.
    MacGillivray ME; Fiorillo L
    J Cutan Med Surg; 2018; 22(6):624-626. PubMed ID: 29754526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.
    Hanfstingl K; Pekar-Lukacs A; Motz R; Guenova E; Hoetzenecker W
    Case Rep Dermatol; 2018; 10(2):97-100. PubMed ID: 29867429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of refractory pityriasis rubra pilaris: challenges and solutions.
    Moretta G; De Luca EV; Di Stefani A
    Clin Cosmet Investig Dermatol; 2017; 10():451-457. PubMed ID: 29184428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical Juvenile Pityriasis Rubra Pilaris: A Case Report of Early Onset With Late Diagnosis.
    Albrakati BA; Alshareef IA; Alhawsawi WK; Al Hawsawi KA
    Cureus; 2022 Oct; 14(10):e30234. PubMed ID: 36381776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS.
    Bonomo RA; Korman N; Nagashima-Whalen L; Briggs J; Graham R; Salata RA
    Am J Med Sci; 1997 Aug; 314(2):118-21. PubMed ID: 9258214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris.
    Sahni MK; Roy K; Asati DP; Khurana U
    Int J Risk Saf Med; 2021; 32(4):261-264. PubMed ID: 34420983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circumscribed Juvenile Pityriasis Rubra Pilaris (Type 4) Koebnerising after a Hot Water Burn: Mild Disease with Maximum Koebner Response.
    Acar EM; Has S; Kilitci A; Kemeriz F
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):47-49. PubMed ID: 31032794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical pityriasis rubra pilaris associated with arthropathy and osteoporosis: a case report with 15-year follow-up.
    Behr FD; Bangert JL; Hansen RC
    Pediatr Dermatol; 2002; 19(1):46-51. PubMed ID: 11860571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
    Camela E; Miano C; Di Caterino P; Lo Presti M; De Fata Salvatores G; Fabbrocini G; Megna M
    Dermatol Ther; 2020 Nov; 33(6):e14223. PubMed ID: 32820849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pityriasis rubra pilaris with erythema gyratum repens-like eruption and resolution with ustekinumab.
    Wong JY; Surgenor L; McCourt C
    Clin Exp Dermatol; 2022 Dec; 47(12):2300-2303. PubMed ID: 35978553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
    Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
    J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis Rubra Pilaris With Extensive Follicular Acantholysis Resembling Pemphigus Vulgaris: A Case Report.
    Lilo MT; Yan S; Chapman MS; Linos K
    Am J Dermatopathol; 2019 Jan; 41(1):37-39. PubMed ID: 30045068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis in a patient with pityriasis rubra pilaris.
    Frikha F; Frigui M; Masmoudi H; Turki H; Bahloul Z
    Pan Afr Med J; 2010 Aug; 6():6. PubMed ID: 21436949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
    Boudreaux BW; Pincelli TP; Bhullar PK; Patel MH; Brumfiel CM; Li X; Heckman MG; Pittelkow MR; Mangold AR; Sluzevich JC
    Br J Dermatol; 2022 Nov; 187(5):650-658. PubMed ID: 35701384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.